Production of human mesenchymal stem cells for allogeneic cell therapies requires
scalable, cost‐effective manufacturing processes. Microcarriers enable the culture of …

The production of stem cells for clinical applications requires a suitable mass expansion and
harvest process, which is implemented in a microcarrier-based bioreactor. Important …

Human mesenchymal stem cells (hMSCs) are a key candidate for advanced cell therapies
with numerous clinical trials investigating their potential to treat acute and chronic …

Human bone marrow‐derived mesenchymal stem cells (hBM‐MSCs) have potential clinical
utility in the treatment of a multitude of ailments and diseases, due to their relative ease of …

Human mesenchymal stromal cells (hMSCs) cells are attractive for applications in tissue
engineering and cell therapy. Because of the low availability of hMSCs in tissues and the …

Human mesenchymal stem/stromal cells (hMSCs) present a key therapeutic cellular
intervention for use in cell and gene therapy (CGT) applications due to their …

Recently, stem cell-based therapies have been proposed as an alternative for the treatment
of many diseases. Stem cells (SCs) are well known for their capacity to preserve themselves …

Human mesenchymal stem cells (hMSCs), also called mesenchymal stromal cells, have
been of great interest in regenerative medicine applications because of not only their …

Human mesenchymal stem cell (hMSC) therapies are currently progressing through clinical
development, driving the need for consistent, and cost effective manufacturing processes to …

Due to their unique features, mesenchymal stem/stromal cells (MSC) have been exploited in
clinical settings as therapeutic candidates for the treatment of a variety of diseases …